Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genetically determined variability in acetylation and oxidation. Therapeutic implications.

D W Clark

    Drugs
    |April 1, 1985
    PubMed
    Summary

    Genetic variations in drug metabolism, specifically acetylation and oxidation, impact drug efficacy and toxicity. Phenotyping can identify slow acetylators, who may need dose adjustments for drugs like isoniazid and sulphasalazine to prevent adverse effects.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    RAD6 promotes DNA repair and stem cell signaling in ovarian cancer and is a promising therapeutic target to prevent and treat acquired chemoresistance.

    Oncogene·2017
    Same author

    An atraumatic femoral fracture in a patient with rheumatoid arthritis and osteoporosis treated with denosumab.

    Case reports in rheumatology·2014
    Same author

    Modern influences in medical practice; undergraduate medical education.

    The West Virginia medical journal·2010
    Same author

    Modern influences in medical practice; undergraduate medical education.

    Connecticut state medical journal·2010
    Same author

    Osteopontin: an effector and an effect of tumor metastasis.

    Current molecular medicine·2010
    Same author

    Hydroxyapatite-ceramic-coated femoral components in young patients followed-up for 16 to 19 years: an update of a previous report.

    The Journal of bone and joint surgery. British volume·2009

    Area of Science:

    • Pharmacogenetics
    • Clinical Pharmacology
    • Drug Metabolism

    Background:

    • Genetic polymorphisms in drug metabolism, particularly acetylation and oxidation, significantly influence individual responses to medications.
    • Phenotyping methods are crucial for assessing these genetic variations and predicting drug behavior in patients.

    Purpose of the Study:

    • To discuss the clinical significance of acetylation and oxidation polymorphisms in drug metabolism.
    • To review phenotyping methods for acetylator and oxidation status.
    • To highlight the implications of these polymorphisms for drug efficacy, toxicity, and disease risk.

    Main Methods:

    • Review of existing literature on drug metabolism polymorphisms.
    • Discussion of dapsone and sparteine phenotyping methods.

    Related Experiment Videos

  • Analysis of clinical data linking acetylator status to drug responses and adverse events.

    • Main Results:

    • Slow acetylators show increased susceptibility to phenytoin and carbamazepine toxicity with isoniazid.
    • Phenotyping may be advisable for suspected drug interactions involving isoniazid.
    • Slow acetylator phenotype is a risk factor for hydralazine-induced systemic lupus erythematosus (SLE).
    • Lower sulphasalazine doses are needed for slow acetylators to manage ulcerative colitis.

    Conclusions:

    • Acetylator phenotyping can guide therapeutic decisions for specific drugs like isoniazid, hydralazine, and sulphasalazine.
    • Understanding acetylation status is important for managing drug toxicity and preventing adverse reactions.
    • Further research is needed to clarify the association between acetylation polymorphism and certain diseases like bladder cancer and idiopathic SLE.